Stephen H. Shoemaker's most recent trade in 180 Life Sciences Corp was a trade of 65,000 Common Stock done . Disclosure was reported to the exchange on Feb. 20, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
180 Life Sciences Corp | Stephen H. Shoemaker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 65,000 | 65,000 | - | 0 | Common Stock |